Citadel Advisors - KAZIA THERAPEUTICS LTD ownership

KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 14 filers reported holding KAZIA THERAPEUTICS LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of KAZIA THERAPEUTICS LTD
ValueSharesWeighting
Q3 2022$24,000
-93.4%
21,500
-75.1%
0.00%
Q2 2022$362,000
+331.0%
86,469
+764.7%
0.00%
Q4 2021$84,000
-83.0%
10,000
-76.8%
0.00%
Q3 2021$495,000
+292.9%
43,085
+237.2%
0.00%
Q2 2021$126,000
+157.1%
12,778
-0.2%
0.00%
Q3 2019$49,0000.0%12,803
-37.5%
0.00%
Q2 2019$49,00020,4730.00%
Other shareholders
KAZIA THERAPEUTICS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Virtu Financial LLC 11,639$120.00%
Allworth Financial LP 87$870.00%
RHUMBLINE ADVISERS 7,555$7,5550.00%
NewEdge Advisors, LLC 500$4980.00%
BNP PARIBAS FINANCIAL MARKETS 8,500$8,4600.00%
BANK OF AMERICA CORP /DE/ 200$1990.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 189,950$189,0380.00%
ACADIAN ASSET MANAGEMENT LLC 18,682$180.00%
Steward Partners Investment Advisory, LLC 25$250.00%
View complete list of KAZIA THERAPEUTICS LTD shareholders